Rates of treatment response and median survival in advanced non small cell lung cancer patients

F. Oztuna, Y. Bulbul, O. Aycicek, T. Ozlu (Trabzon, Turkey)

Source: Annual Congress 2004 - Chemotherapy, targeted therapies costs and outcomes
Session: Chemotherapy, targeted therapies costs and outcomes
Session type: Thematic Poster Session
Number: 1943
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Oztuna, Y. Bulbul, O. Aycicek, T. Ozlu (Trabzon, Turkey). Rates of treatment response and median survival in advanced non small cell lung cancer patients. Eur Respir J 2004; 24: Suppl. 48, 1943

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009


Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005

Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009


Tobacco exposure and survival in non small cell lung cancer patients treated with erlotinib
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Small cell lung cancer patients and their responses to treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 301s
Year: 2004

Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Gefitinib in the non small cell lung cancer treatment: contribution to prolongation and quality of survival
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019


Determinants of relapse and survival in completely ressected non small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients
Source: Eur Respir J 2002; 20: Suppl. 38, 464s
Year: 2002

Survival of patients with relapsing small cell lung cancer (SCLC) after new line chemotherapy administration
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005

The effect on disease free survival of different regimens of chemotherapy (CT) in non small cell lung cancer (NSCLC)
Source: Eur Respir J 2004; 24: Suppl. 48, 672s
Year: 2004

Does long treatment delay affect survival in metastatic non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival
Source: Eur Respir J 2007; 30: Suppl. 51, 280s
Year: 2007

Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Second-line treatment patients at relapse of disseminated small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001

Pattern of relapse in stage I N0 non small cell lung cancer
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009